Blood-Based Biomarkers Could Reshape Soft Tissue Sarcoma Therapy

Immunotherapy may be a meaningful therapeutic option for certain patients with soft tissue sarcomas (STS), but more research is needed to identify strong biomarkers of treatment response, according to a new review article.¹

The article, which was…